CA-SCIENTIST.COM
Scientist.com, the pharmaceutical industry’s leading R&D marketplace, announced today that VERIF.i® , the company’s supplier pre-assessment program, has been used to successfully complete an on-site assessment of the LIDE Biotech facility in Shanghai, China. VERIF.i was developed to help users on both sides of the Scientist.com marketplace improve quality standards and reduce indirect costs.
LIDE (Lab for Innovated Diagnosis and Experimental Therapeutics) Biotech is a translational medicine service provider that has delivered innovations in oncology translational research and immune-oncology for the past 11 years. LIDE was founded by overseas returnees Drs. Danyi Wen, Yizhun Zhu and others, with the goal of bringing together first-class research and management teams with advanced scientific backgrounds to push the frontier of translational medical research. LIDE is committed to superior research quality; in 2015, it partnered with several large pharma and biotech companies to create a PDX Consortium Board with the goal of promoting and ensuring high PDX standards across China.
“At LIDE we hold ourselves to the highest industry standards by ensuring superior quality of our facilities and the world class scientists operating them,” stated Dr. Danyi Wen, President and CEO of LIDE Biotech. “Together with other industry certifications, VERIF.i allows us to showcase our quality commitment across the industry in North America and Europe as well as in the growing Scientist.com marketplace.”
VERIF.i gives suppliers of regulated research services the opportunity to proactively communicate their standards against pre-defined criteria developed for the biopharma industry and then confirm them through independent, third-party auditors that carry out an on-site inspection. Pre-assessments help suppliers such as LIDE Biotech demonstrate their quality and capabilities, while also helping pharma and biotech customers purchase regulated services in an accelerated manner with more confidence and less risk.
“Even prior to the Covid-19 pandemic, on-site assessments of laboratories were difficult to complete owing to the high cost and intensive resource and time requirements,” stated Matt McLoughlin, SVP of Categories and Compliance at Scientist.com . “VERIF.i addresses these challenges by creating a standardized process for both customers and suppliers. It also enables suppliers like LIDE to differentiate themselves from their peers by sharing independent insight into their facilities, personnel and processes."
VERIF.i is an expansion of Scientist.com’s award-winning COMPLi® solution. For more information visit https://www.scientist.com/verifi/
About LIDE Biotech
LIDE biotech is committed to accelerating translation from pre-clinical to clinical for our clients. We do this through our unique access to fresh patient samples, received daily via our close hospital partnerships across China. These relationships combined with our proprietary kits, tumor sample kit, CRC kit, MiniPDX assay kit, and K-Cell kits, LIDE’s platform gives our clients the competitive edge to save time and budget. Based on this success, LIDE has built a robust database of over 1600+ PDX, CDX, and Cell Line models which grows daily. Our CRO services can be custom tailored based on what stage of the pre-clinical oncology drug development process you’re in, including clinical biopsy collection, in vitro/in vivo studies, transcription RNA and DNA analysis, and Immuno-Oncology capabilities.
LIDE Biotech will be at the American Association for Cancer Research Annual Meeting in New Orleans from April 10 – 13. Stop by First Floor Exhibit Hall D-H, Booth # 2057.
Watch LIDE Biotech’s Director of Immuno-Oncology, Dr. Bin Xie discuss current and novel Immuno-Oncology drug evaluation methods via humanized mouse models on a Scientist.com-hosted webinar.
Visit www.lidebiotech.com to learn more and follow updates on the LIDE Biotech LinkedIn page.
About Scientist.com
Scientist.com’s mission is to empower and connect scientists worldwide. By transforming the way scientific research is performed, our Science as a Service® platform accelerates discoveries that prevent and cure disease, address climate change and help secure global food and energy supplies. We combine sophisticated AI technology with white-glove Research Concierge® support to enable scientists to run more innovative experiments in less time and at lower cost.
Visit scientist.com to learn more.
Join Scientist.com on social media: LinkedIn , Twitter , YouTube , Facebook and Instagram
View source version on businesswire.com: https://www.businesswire.com/news/home/20220323005725/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
SS&C Technologies Completes Acquisition of Curo Fund Services12.11.2025 14:45:00 CET | Press release
The acquisition will grow SS&C’s business in South Africa SS&C Technologies Holdings, Inc. (Nasdaq: SSNC) has completed the acquisition of Curo Fund Services, a leading South African provider of fund administration solutions, from a joint venture between Sanlam and Old Mutual. Terms of the deal were not disclosed. Curo Fund Services administers more than R 3 trillion (USD 170.4 billion) in assets and services Sanlam, Old Mutual and third-party institutional clients. Around 300 employees have joined SS&C in Cape Town. The team will be part of SS&C Global Investor & Distribution Solutions, led by Nick Wright. The merger will provide South African clients with access to SS&C’s automation, data and global operational expertise. Curo is positioned to expand its fund administration offerings, grow market share and accelerate growth across South Africa and the African continent. Curo Fund Services already leverages several of SS&C’s fund accounting and asset servicing technologies. The transa
Columbia Sportswear Company Advances Its Succession Plans and Appoints Co-Presidents, Peter J. Bragdon and Joseph P. Boyle12.11.2025 14:45:00 CET | Press release
Columbia Sportswear Company (Nasdaq: COLM, the “Company”), a global leader in designing, sourcing, marketing, and distributing outdoor, active and everyday lifestyle apparel, footwear, accessories, and equipment products, today announced that as part of its ongoing process to advance its succession plans, it has implemented some changes to its senior leadership team. The Board of Directors (the “Board”) has appointed Peter J. Bragdon and Joseph P. Boyle as co-presidents, effective November 12, 2025. Mr. Bragdon has been appointed President of the Company and will oversee all of the Company’s international businesses, the Mountain Hardwear brand, the prAna brand, and the SOREL brand, while continuing his existing executive oversight of certain administrative and international distributor sales functions. Mr. Joseph P. Boyle has been appointed President, Columbia Brand and will continue to oversee the Company’s Columbia brand, including the North America business, which was recently cons
Corpay Cross-Border Named the Official FX Partner for BLAST12.11.2025 14:30:00 CET | Press release
Providing access to currency risk management and cross-border payments solutions Corpay, Inc.* (NYSE: CPAY), a global leader in corporate payments, today announced that its Cross-Border business has entered into a multi-year agreement with the BLAST, a global competitive entertainment company with a mission to bring mega entertainment to the world, taking esports, gaming and other new competitive formats to the next level. Under the agreement, Corpay will serve as their Official Foreign Exchange Partner. Through this partnership, BLAST will be able to use Corpay Cross-Border’s innovative solutions to help mitigate foreign exchange exposure in their daily operations. They’ll also benefit from Corpay’s award-winning platform, which allows for seamless global payment management from a single point of access. “Corpay is thrilled to be named the Official FX Partner for BLAST, a true pioneer in the world of esports,” said Brad Loder, Chief Marketing Officer, Corpay Cross-Border Solutions. “T
De' Longhi S.p.A. - Another Record Quarter: Revenues at €877 Million, up 11.5% at Constant Currency, and Adjusted EBITDA Margin at 17.0%. Guidance Raised12.11.2025 14:29:00 CET | Press release
The leadership position in the home coffee market allows the Group to achieve significant growth, thanks to the structural trend of espresso’s expansion and premiumization, further strengthened by the strong expansion of the professional division Approved by the Board of Directors of De' Longhi S.p.A. the consolidated results for the nine months of 2025. In the nine months the Group achieved: revenues for € 2,461.4 million, up by 10.4% with respect to 2024 (11.7% at constant currency); an adjusted Ebitda of € 389.5 million, equal to 15.8% on revenues (vs. 15.1% last year); a net income pertaining to the Group equal to € 187.6 million (+8.0% with respect to last year); a positive net financial position equal to € 308.7 million. In the third quarter the Group achieved: revenues for € 877.2 million, up by 8.9% with respect to 2024 (11.5% at constant currency); an adjusted Ebitda of € 148.8 million, or 17.0% on revenues (vs. 16.3% last year) a net income pertaining to the Group amounting t
World Leaders and Industry Icons Unite Under BRIDGE Alliance to Empower the Future of Media, Entertainment and Content12.11.2025 14:11:00 CET | Press release
A new international alliance of policymakers, creative leaders, and innovators has come together under the banner of BRIDGE Alliance to advance inclusivity, investment, and sustainable development in the global media, entertainment and content economy. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251112707768/en/ World leaders and industry icons unite under BRIDGE Alliance to empower the future of media, entertainment and content (Photo: AETOSWire) Headquartered in the UAE, BRIDGE Alliance stands as a first-of-its-kind global body chaired by H.E. Abdulla bin Mohammed bin Butti Al Hamed. It brings together an influential board comprising former heads of state, global leaders, policymakers, and CEOs from the media, communication, technology, finance, and creative sectors. The founding board includes HRH Princess Lamia bint Majed Al Saud, CEO of Rotana Media Group and Secretary-General of Alwaleed Philanthropies; H.E. Macky S
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom